Effects of calcium, inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts. 2001

J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
Laboratory for Physiology, Department of Cardiology, Institute for Cardiovascular Research, Free University, Amsterdam, the Netherlands. J.van_der_Velden.physiol@med.vu.nl

BACKGROUND During ischemia, the intracellular calcium and inorganic phosphate (P(i)) concentrations rise and pH falls. We investigated the effects of these changes on force development in donor and failing human hearts to determine if altered contractile protein composition during heart failure changes the myocardial response to Ca(2+), P(i), and pH. RESULTS Isometric force was studied in mechanically isolated Triton-skinned single myocytes from left ventricular myocardium. Force declined with added P(i) to 0.33+/-0.02 of the control force (pH 7.1, 0 mmol/L P(i)) at 30 mmol/L P(i) and increased with pH from 0.64+/-0.03 at pH 6.2 to 1.27+/-0.02 at pH 7.4. Force dependency on P(i) and pH did not differ between donor and failing hearts. Incubation of myocytes in a P(i)-containing activating solution caused a potentiation of force, which was larger at submaximal than at maximal [Ca(2+)]. Ca(2+) sensitivity of force was similar in donor hearts and hearts with moderate cardiac disease, but in end-stage failing myocardium it was significantly increased. The degree of myosin light chain 2 phosphorylation was significantly decreased in end-stage failing compared with donor myocardium, resulting in an inverse correlation between Ca(2+) responsiveness of force and myosin light chain 2 phosphorylation. CONCLUSIONS Our results indicate that contractile protein alterations in human end-stage heart failure alter Ca(2+) responsiveness of force but do not affect the force-generating capacity of the cross-bridges or its P(i) and pH dependence. In end-stage failing myocardium, the reduction in force by changes in pH and [P(i)] at submaximal [Ca(2+)] may even be less than in donor hearts because of the increased Ca(2+) responsiveness.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right

Related Publications

J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
September 1996, Cardiovascular research,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
January 1986, The Journal of physiology,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
December 2001, Journal of cardiac failure,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
August 1994, The Journal of physiology,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
August 1988, Pflugers Archiv : European journal of physiology,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
May 1994, The Journal of physiology,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
January 2004, Journal of muscle research and cell motility,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
January 2015, Cardiovascular research,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
October 1996, British journal of pharmacology,
J van Der Velden, and L J Klein, and R Zaremba, and N M Boontje, and M A Huybregts, and W Stooker, and L Eijsman, and J W de Jong, and C A Visser, and F C Visser, and G J Stienen
March 1995, Cardiovascular research,
Copied contents to your clipboard!